Entries by PR Newswire

, , , , , , , , , , ,

Jeff Winton Associates Expands Global Healthcare Communications Services

Jeff Winton Associates, a full-service communications agency for the pharmaceutical, biotechnology and other life sciences industries, announced expansion into additional global markets through a new partnership with UK-based marketing communications firm Onyx Health.

, , , , , , , ,

“Disappearing Doctors” Provides Crucial Mental Health Support for Physicians as Pandemic Threatens to Exacerbate Doctor Suicide Crisis

In recognition of World Suicide Prevention Day, FCB Health New York announced the launch of “Disappearing Doctors,” a pro bono initiative advocating for and providing mental health support to physicians in need, in partnership with Sermo, Haymarket Media Group and the National Suicide Prevention Lifeline.

, , , , , , , ,

U.S. FDA Approves Athena Bioscience’s New Drug Application for Qdolo

The U.S. Food and Drug Administration approved Athena Bioscience LLC’s Qdolo (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

, , , , , , ,

New Research Paper Suggests RegeneRx’s Thymosin Beta 4 May be Useful in Treating Covid-19

RegeneRx Biopharmaceuticals Inc. announced that a multi-institutional team of scientists from eight American research centers published a research paper on new therapeutic approaches for Covid-19 in which they propose that Thymosin beta 4 (Tβ4), because of its ability to induce fibrinolysis, among other activities, may be useful in treating patients with the Covid-19 virus.

, , , , , , , , , , , ,

FDA Approves New Kyprolis Combination Regimen

The U.S. Food and Drug Administration approved the expansion of Amgen’s Kyprolis (carfilzomib) U.S. prescribing information to include the product’s use in combination with Darzalex (daratumumab) plus dexamethasone (DKd) in two dosing regimens – once weekly and twice weekly – for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three previous lines of therapy.

, , , , , , , , , ,

EVERSANA and Havas Health & You announce exclusive strategic partnership

EVERSAN and Havas Health & You announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.

, , , , ,

Outcome Health and Leading Healthcare Organizations #ShareTheScope in One-Day Social Media Turnover for Equity and Justice in Healthcare

Outcome Health and seven leading organizations in healthcare marketing, media, content creation and advocacy will #ShareTheScope in a one-day campaign on July 22 by turning over their social media channels to eight organizations and influencers focused on health issues and disparities facing the Black community.